🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › New Jersey › Newark

Etid klinik pou Sendwòm myelodisplastik nan Newark, NJ

4 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Newark (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06577441

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • Atlantic Health, Morristown · 17 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Newark

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.